Skip to main content
. 2017 Oct 6;8(54):92890–92903. doi: 10.18632/oncotarget.21641

Figure 3. PD-L1 expression is a prognostic factor in VSCC.

Figure 3

The membranous expression of PD-L1 in cancer cells was determined by immunohistochemistry; cumulative incidence analysis was performed using competing risk regression (death from VSCC was the main event and death from other causes the competing risk approach); results of Gray's test are provided.